Healthcare

The recent foray by telehealth company Hims & Hers into the lucrative weight-loss medication sector has hit an early regulatory...

Despite posting impressive fourth-quarter 2025 results, Intuitive Surgical's forward-looking guidance has unsettled investors. The stock has retreated significantly from recent...

NextGen Healthcare continues to demonstrate robust market strength, underscored by a key new client partnership and a series of prestigious...

Investors are marking their calendars for a pivotal date in late February 2026. National Healthcare is poised to release its...

Biopharmaceutical firm aTyr Pharma (ATYR) has scheduled a critical regulatory discussion with the U.S. Food and Drug Administration (FDA) for...

All eyes are on Align Technology as the company prepares to release its fourth-quarter financial results after today's market close....

Biotechnology firm Bionxt Solutions has moved a step closer to testing a novel multiple sclerosis treatment in humans. The company's...

ImmunityBio has initiated a new clinical study, marking a strategic expansion of its development pipeline. The U.S. biotechnology firm announced...

Acadia Pharmaceuticals has encountered a significant obstacle for its European expansion strategy. Market uncertainty followed the announcement of a negative...

Shares of UnitedHealth Group came under significant pressure this week following a regulatory announcement that fell dramatically short of industry...